JOMDD announces its investment in Luxonus – Ultra-high resolution 3D imaging of blood vessels and lymph vessels –
JOMDD announces its investment in Luxonus, a venture company developing diagnostic imaging devices.
Luxonus Co. Ltd. is developing a general purpose imaging device that uses proprietary Photoacoustic Imaging (PAI) technology to enable early-stage disease detection and diagnosis (fusion of two technologies, ultrasound imaging in the body and high resolution of optical imaging).
The venture company was established on the basis of results from programs including the Japan Science and Technology Agency’s Impulsing Paradigm Change through Disruptive Technology Program (ImPACT).
About Luxonus Co. Ltd.